UPDATE: Gilead to Buy YM BioSciences for $2.95/Share in Cash

Gilead Sciences, Inc. (Nasdaq: GILD ) and YM BioSciences Inc. (NYSE: YMI, TSX: YM) announced today that the companies have signed a definitive agreement under which Gilead will acquire YM for U.S.$2.95 per share in cash. The transaction has received the unanimous approval of YM's Board of Directors, and values YM at approximately